PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE pharmaceutical API fine chemical vendors

Subscribe to access the full database, or Get Started Free
Vendor	Vendor Homepage	Vendor Sku	API Url
Starshine Chemical	⤷ Get Started Free	2023-05-5H02882	⤷ Get Started Free
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: November 17, 2025

Introduction

In the pharmaceutical supply chain, sourcing high-quality Active Pharmaceutical Ingredients (APIs) is critical for ensuring medication efficacy, safety, and regulatory compliance. For formulations containing Promethazine Hydrochloride, Phenylephrine Hydrochloride, and Codeine Phosphate, understanding the global landscape of reliable API suppliers enables manufacturers to optimize procurement strategies, maintain supply continuity, and meet quality standards. This analysis evaluates the primary sources for these APIs, considering manufacturing capacities, regulatory status, and geographic distribution.

Overview of APIs

Promethazine Hydrochloride
A first-generation phenothiazine derivative primarily used as an antiemetic, antihistamine, and sedative. It requires strict quality control due to its central nervous system activity and potential side effects.

Phenylephrine Hydrochloride
A sympathomimetic agent used as a decongestant. Its wide application demands consistent quality from diverse sources, especially for over-the-counter (OTC) and prescription formulations.

Codeine Phosphate
An opioid analgesic and antitussive, regulated under strict international controls due to its potential for misuse. Sourcing reputable API suppliers must align with regulatory frameworks like the DEA (USA), MHRA (UK), and equivalent agencies globally.

Global API Manufacturing Landscape

The production of these APIs is concentrated in several key regions, notably India, China, Europe, and North America. The Indian pharmaceutical industry has emerged as a dominant API supplier, leveraging cost advantages and extensive manufacturing expertise. China similarly commands a significant share, especially for bulk intermediates and raw materials. European and North American manufacturers primarily focus on compliance with strict regulatory standards to service premium markets.

Primary API Suppliers

1. India

India's pharmaceutical sector accounts for approximately 20% of the global API production capacity, with hundreds of API manufacturers accredited under WHO GMP, EU, and US FDA standards. Promethazine Hydrochloride, Phenylephrine Hydrochloride, and Codeine Phosphate are extensively produced with proven compliance.

Promethazine Hydrochloride:
Major Indian API manufacturers, such as Sun Pharma, Cipla, and Morepen Laboratories, supply Promethazine API meeting international standards. These companies have established robust GMP compliance and pronounced export footprints.
Phenylephrine Hydrochloride:
Indian firms like Aurobindo Pharma and Lupin produce pharmaceutical-grade Phenylephrine, often used in OTC products globally. Their quality systems ensure consistent potency and stability.
Codeine Phosphate:
Indian suppliers such as Cadila Healthcare and Sanofi India are significant providers, strictly regulated, with export licenses granted for global supply, primarily to regions with less stringent opioid controls.

2. China

China remains a cornerstone for raw materials and intermediates pivotal in API synthesis.

Promethazine Hydrochloride:
Several Chinese API manufacturers supply Promethazine, often as intermediates or finished APIs, with competitive pricing. However, regulatory compliance and quality assurance vary among producers.
Phenylephrine Hydrochloride & Codeine Phosphate:
Leading Chinese companies like Shandong Xinhua Pharmaceutical and Shenzhen Southwest Pharmaceutical produce APIs with growing EMA and FDA approvals.
Regulatory Status:
The Chinese government has initiated regulatory reforms to improve GMP standards, which enhances the reliability of Chinese API sources especially for APIs like Codeine, subject to tight international opioid control.

3. Europe

European APIs are renowned for stringent quality and regulatory compliance.

Notable Suppliers:
Recipharm, Evonik, and Solara Active Pharma Sciences manufacture high-grade Promethazine, Phenylephrine, and Codeine APIs.
Quality Assurance:
European suppliers benefit from rigorous GMP standards aligned with EMA regulations, making them preferred for markets with high regulatory scrutiny.

4. North America

The United States and Canada emphasize high-quality API manufacturing.

Key Players:
FMC Corporation, Siegfried, and DSM Pharmaceutical provide APIs either domestically or via strategic partnerships with Asian manufacturers.
Regulatory Considerations:
US-FDA inspected facilities ensure APIs meet stringent quality norms, but costs are higher, sometimes influencing sourcing decisions for large-scale production.

Regulatory and Quality Considerations

Given the narrow therapeutic indices and regulatory sensitivity, especially with Codeine Phosphate, all API suppliers must comply with Good Manufacturing Practices (GMP), undergo rigorous quality testing, and provide comprehensive documentation. Suppliers with a proven track record of regulatory compliance, consistent batch quality, and capacity to meet supply timelines are preferred.

Supply Chain Challenges

Regulatory Restrictions:
Opioids like Codeine Face strict international controls, complicating sourcing in regions with tight regulations.
Geopolitical Risks:
Political tensions and trade policies influence the stability and price of Asian API imports.
Quality Assurance:
Variations in manufacturing standards across suppliers necessitate audits, certifications, and ongoing compliance verification.

Emerging Trends and Future Outlook

The industry is gradually shifting toward API manufacturing diversification, with increased investments in regional manufacturing hubs in Europe and North America. Advances in continuous manufacturing and quality-by-design (QbD) principles are expected to elevate API quality standards globally, reducing supplier dependence on a few regions.

Furthermore, regulatory agencies emphasize transparency and batch traceability, prompting suppliers to enhance documentation and quality control systems.

Conclusion

Sourcing bulk APIs for Promethazine Hydrochloride, Phenylephrine Hydrochloride, and Codeine Phosphate necessitates a nuanced understanding of regional manufacturing capabilities, regulatory environments, and quality standards. Indian and Chinese suppliers dominate due to capacity and cost advantages, yet European and North American entities provide high-assurance sources aligned with stringent compliance requirements. Strategic supplier selection should consider regulatory status, historical quality performance, and supply reliability to mitigate risks and ensure continuous product supply.

Key Takeaways

Indian API manufacturers lead in production capacity for Promethazine, Phenylephrine, and Codeine, but require rigorous qualification processes.
Chinese suppliers offer cost-competitive APIs, yet variability in quality assurance necessitates diligent supplier verification.
European and North American API producers provide high-quality, GMP-compliant APIs suitable for stringent regulatory jurisdictions.
Regulatory controls, especially on opioids, influence global sourcing strategies, with compliance paramount.
Diversification and supplier audits are essential for mitigating geopolitical, regulatory, and quality risks in the API supply chain.

FAQs

1. Are Indian API suppliers FDA-approved?
Many Indian API manufacturers have FDA approval or inspection clearance, particularly for APIs intended for export to regulated markets. Certification and audit reports should be confirmed during qualification.

2. How does China’s API regulatory environment affect supply quality?
China’s improvements in GMP standards and increased regulatory oversight have elevated API quality. However, variability persists among suppliers; rigorous supplier qualification remains essential.

3. Is it feasible to source high-quality Codeine Phosphate from North America?
Yes. North American suppliers like FMC and Siegfried manufacture GMP-compliant Codeine APIs, primarily for the US, Canada, and regulated export markets, though costs tend to be higher.

4. What are the risks associated with sourcing APIs from emerging regions?
Risks include inconsistent quality, regulatory non-compliance, geopolitical instability, and supply chain disruptions, especially for APIs like Codeine subjected to international controls.

5. How can manufacturers ensure API quality and regulatory compliance?
Through comprehensive supplier qualification, regular audits, review of certificates of analysis, regulatory documentation, and adherence to current GMP standards.

References

[1] WHO. WHO List of Essential Medicines. 2022.
[2] US Food and Drug Administration. API Supplier Directory. 2023.
[3] IQVIA Institute Reports. Global API Market Trends. 2022.
[4] European Medicines Agency. Regulatory Guidelines for APIs. 2023.
[5] Industry Reports on API Manufacturing & Supply Chain. 2022.

This comprehensive analysis aims to assist pharmaceutical manufacturers and procurement professionals in establishing reliable supply chains for Promethazine Hydrochloride, Phenylephrine Hydrochloride, and Codeine Phosphate APIs, ensuring compliance, quality, and operational resilience.

Bulk Pharmaceutical API Sources for PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE